Although it is not known whether enhanced S100A6 expression is the cause or effect of pathological changes, it is rather certain that S100A6 has its share in the severity and progress of many diseases, since its knockdown in cellular or animal disease models usually alleviates the symptoms. This evidence concerns the gene S100A6 and glycogen storage disease VI.